[Federal Register Volume 84, Number 62 (Monday, April 1, 2019)]
[Notices]
[Page 12256]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06146]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--CE19-004, Etiologic and Effectiveness Research To 
Address Polysubstance Impaired Driving; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)-CE19-004, Etiologic and Effectiveness Research to Address 
Polysubstance Impaired Driving; May 7-8, 2019; 8:30 a.m.-5:30 p.m., 
(EDT) which was published in the Federal Register on February 15, 2019, 
Volume 84, Number 32, page/s/4446-4447.
    The meeting is being amended to change the meeting location to The 
W Buckhead, 3377 Peachtree Road, NE, Atlanta, GA 30326]. The meeting is 
closed to the public.

FOR FURTHER INFORMATION CONTACT: Mikel L. Walters, M.A., Ph.D., 
Scientific Review Official, NCIPC, CDC, 4770 Buford Highway NE, 
Mailstop F-63, Atlanta, Georgia 30341,(404) 639-0913; [email protected].
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-06146 Filed 3-29-19; 8:45 am]
 BILLING CODE 4163-18-P